Intellia Therapeutics (NTLA) FCF Margin (QoQ) (2015 - 2026)
Intellia Therapeutics (NTLA) FCF Margin (QoQ) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Intellia Therapeutics |
1.86 Bn |
1.86 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-47,918.00 |
| Dec 31, 2025 |
25,681.00 |
| Sep 30, 2025 |
14,080.00 |
| Jun 30, 2025 |
19,743.00 |
| Mar 31, 2025 |
-26,722.00 |
| Dec 31, 2024 |
34,789.00 |
| Sep 30, 2024 |
-16,746.00 |
| Jun 30, 2024 |
-38,374.00 |
| Mar 31, 2024 |
-527,841.00 |
| Dec 31, 2023 |
564,327.00 |
| Sep 30, 2023 |
-9,446.00 |
| Jun 30, 2023 |
20,160.00 |
| Mar 31, 2023 |
-20,673.00 |
| Dec 31, 2022 |
-6,706.00 |
| Sep 30, 2022 |
-535.00 |
| Jun 30, 2022 |
12,376.00 |
| Mar 31, 2022 |
-29,481.00 |
| Dec 31, 2021 |
2.27 Mn |
| Sep 30, 2021 |
-2.23 Mn |
| Jun 30, 2021 |
-5,015.00 |
